Found: 6
Select item for more details and to access through your institution.
Serum Cyfra 21.1 and galectin-3 protein levels in relation to immunohistochemical cytokeratin 19 and galectin-3 expression in patients with thyroid tumors.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2010, v. 136, n. 12, p. 1805, doi. 10.1007/s00432-010-0838-3
- By:
- Publication type:
- Article
Combined immunohistochemistry for thyroid peroxidase, galectin-3, CK19 and HBME-1 in differential diagnosis of thyroid tumors.
- Published in:
- APMIS, 2012, v. 120, n. 5, p. 368, doi. 10.1111/j.1600-0463.2011.02842.x
- By:
- Publication type:
- Article
Galectin-3 expression in papillary thyroid carcinoma: Relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
- Published in:
- Head & Neck, 2005, v. 27, n. 12, p. 1049, doi. 10.1002/hed.20276
- By:
- Publication type:
- Article
MOGUĆNOSTI CITOLOGIJE U DIFERENCIJALNOJ DIJAGNOZI TIROIDNOG NODUSA.
- Published in:
- Medical Gazette / Medicinski Glasnik, 2011, v. 16, n. 40, p. 19
- By:
- Publication type:
- Article
Thyroid peroxidase immunohistochemistry in differential diagnosis of thyroid tumors.
- Published in:
- Endocrine Pathology, 2006, v. 17, n. 1, p. 53, doi. 10.1385/EP:17:1:53
- By:
- Publication type:
- Article
Cytokeratin19 expression discriminates papillary thyroid carcinoma from other thyroid lesions and predicts its aggressive behavior.
- Published in:
- Medical Oncology, 2013, v. 30, n. 1, p. 1, doi. 10.1007/s12032-012-0362-1
- By:
- Publication type:
- Article